A recent study published in The Lancet Infectious Diseases journal reveals that the use of metformin, a widely available and low-cost diabetes medication, reduces the risk of developing long COVID by 41 percent.  Meanwhile, ivermectin, another drug that has been the subject of much debate and scrutiny, showed no significant impact on the incidence of…